Possible catecholamine mediation of levallorphan-induced behavioural disruption in rats.
D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002395:Catecholamines / Q000378:metabolism*; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal; D007977:Levallorphan / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D009043:Motor Activity / Q000187:drug effects; D051381:Rats; D013239:Stereotyped Behavior / Q000187:drug effects; D013647:Task Performance and Analysis; D014443:Tyrosine / Q000008:administration & dosage / Q000494:pharmacology
D002395:Catecholamines; D007977:Levallorphan; D014443:Tyrosine